FEDERATED HERMES, INC. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$1,0000.0%70.0%0.00%
Q3 2021$1,000
-80.0%
7
-93.9%
0.00%
Q2 2021$5,000
-99.6%
115
-99.6%
0.00%
-100.0%
Q1 2021$1,356,000
-51.2%
27,491
-58.3%
0.00%
-50.0%
Q4 2020$2,779,000
-21.7%
66,004
-14.9%
0.01%
-25.0%
Q3 2020$3,550,000
-8.3%
77,549
+0.6%
0.01%
-20.0%
Q2 2020$3,871,000
+196.6%
77,104
+203.9%
0.01%
+150.0%
Q1 2020$1,305,000
+14400.0%
25,371
+17766.9%
0.00%
Q4 2019$9,000
-98.2%
142
-98.3%
0.00%
-100.0%
Q3 2019$497,000
-28.5%
8,273
+0.4%
0.00%
-50.0%
Q2 2019$695,000
-32.9%
8,236
-24.1%
0.00%
-33.3%
Q1 2019$1,036,000
-65.7%
10,846
-74.5%
0.00%
-62.5%
Q4 2018$3,018,000
-37.3%
42,607
-24.4%
0.01%
-27.3%
Q3 2018$4,814,000
-38.5%
56,332
-16.6%
0.01%
-52.2%
Q2 2018$7,829,000
+195625.0%
67,552
+132354.9%
0.02%
Q1 2018$4,000
-50.0%
51
-79.6%
0.00%
Q1 2017$8,000
-46.7%
250
-45.7%
0.00%
Q4 2016$15,000
-96.1%
460
-96.3%
0.00%
-100.0%
Q1 2015$386,000
-68.5%
12,591
-47.8%
0.00%
-75.0%
Q4 2014$1,226,000
+32.3%
24,112
+2.9%
0.00%
+33.3%
Q3 2014$927,000
+11487.5%
23,429
+13062.4%
0.00%
Q2 2014$8,0001780.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders